Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Research Network

Collaboration Network

48 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nai-Kong V. Cheung, MD, PhD

Memorial Sloan Kettering Cancer Center

Moderately Similar
9 trials

Shared therapeutic areas:

LeukemiaLymphomaLymphoproliferative Disorders

Worked with same sponsors:

Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score34%

Shakeel Modak, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
10 trials

Shared therapeutic areas:

LeukemiaLymphomaLymphoproliferative Disorders

Worked with same sponsors:

Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score34%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
13 trials

Shared therapeutic areas:

LymphomaLeukemiaLymphoproliferative Disorders

Worked with same sponsors:

Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score34%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLymphoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score25%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaGraft vs Host Disease+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Graft vs Host DiseaseLeukemiaLymphoma+1 more
Similarity Score20%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host DiseaseLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Myelodysplastic SyndromesGraft vs Host DiseaseLymphoma
Similarity Score15%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00014469Phase 2StudyChair

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Completed
NCT00087009Phase 1PrincipalInvestigator

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

LeukemiaLymphomaLymphoproliferative Disorder
Terminated

All 2 trials loaded